Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:COCH NASDAQ:PDEX NASDAQ:RXST NASDAQ:VANI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$0.64-1.5%$0.68$0.36▼$1.89$49.20M1.9460,181 shs53,337 shsPDEXPro-Dex$64.79+2.2%$59.39$23.47▼$68.99$206.83M-0.0233,860 shs28,316 shsRXSTRxSight$5.39+3.2%$5.94$4.48▼$13.96$223.13M1.14878,404 shs193,095 shsVANIVivani Medical$1.19$1.22$0.92▼$1.92$102.62M2.31272,099 shs91,058 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical-1.54%+0.25%-8.32%-5.00%-53.57%PDEXPro-Dex-1.57%+1.72%-0.20%+30.41%+51.58%RXSTRxSight+5.24%+11.54%-14.29%-20.79%-61.45%VANIVivani Medical+5.31%+1.71%-0.83%+5.31%-5.56%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$0.64-1.5%$0.68$0.36▼$1.89$49.20M1.9460,181 shs53,337 shsPDEXPro-Dex$64.79+2.2%$59.39$23.47▼$68.99$206.83M-0.0233,860 shs28,316 shsRXSTRxSight$5.39+3.2%$5.94$4.48▼$13.96$223.13M1.14878,404 shs193,095 shsVANIVivani Medical$1.19$1.22$0.92▼$1.92$102.62M2.31272,099 shs91,058 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical-1.54%+0.25%-8.32%-5.00%-53.57%PDEXPro-Dex-1.57%+1.72%-0.20%+30.41%+51.58%RXSTRxSight+5.24%+11.54%-14.29%-20.79%-61.45%VANIVivani Medical+5.31%+1.71%-0.83%+5.31%-5.56%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOCHEnvoy Medical 2.00Hold$2.50290.63% UpsidePDEXPro-Dex 2.33Hold$70.008.03% UpsideRXSTRxSight 1.93Reduce$9.4475.38% UpsideVANIVivani Medical 2.25Hold$3.75215.13% UpsideCurrent Analyst Ratings BreakdownLatest COCH, VANI, RXST, and PDEX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/23/2026VANIVivani Medical Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$4.006/23/2026VANIVivani Medical Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$4.006/11/2026RXSTRxSight Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/9/2026VANIVivani Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/22/2026RXSTRxSight Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/19/2026PDEXPro-Dex Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/12/2026PDEXPro-Dex Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$56.00 ➝ $70.005/7/2026RXSTRxSight Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/7/2026RXSTRxSight Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$11.00 ➝ $9.005/7/2026RXSTRxSight Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$13.00 ➝ $11.005/1/2026PDEXPro-Dex Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOCHEnvoy Medical$240K205.01N/AN/A($0.42) per share-1.52PDEXPro-Dex$66.59M3.10$3.15 per share20.54$11.23 per share5.77RXSTRxSight$127.48M1.75N/AN/A$6.70 per share0.80VANIVivani MedicalN/AN/AN/AN/A$0.20 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOCHEnvoy Medical-$23.76M-$1.01N/AN/AN/A-9,875.64%N/A-177.92%7/30/2026 (Estimated)PDEXPro-Dex$8.98M$3.6217.9123.31N/A16.08%22.78%14.30%7/8/2026 (Estimated)RXSTRxSight-$38.94M-$1.13N/AN/AN/A-36.58%-17.01%-15.12%8/6/2026 (Estimated)VANIVivani Medical-$26.61M-$0.40N/AN/AN/AN/A-264.04%-79.85%8/12/2026 (Estimated)Latest COCH, VANI, RXST, and PDEX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026VANIVivani Medical-$0.08-$0.08N/A-$0.08N/AN/A5/11/2026Q1 2026COCHEnvoy Medical-$0.14-$0.11+$0.03-$0.08$0.10 million$0.04 million4/30/2026Q3 2026PDEXPro-Dex$0.62$1.20+$0.58$1.20$17.90 million$19.95 million3/26/2026Q4 2025VANIVivani Medical-$0.10-$0.09+$0.01-$0.09N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCOCHEnvoy MedicalN/AN/AN/AN/AN/APDEXPro-DexN/AN/AN/AN/AN/ARXSTRxSightN/AN/AN/AN/AN/AVANIVivani MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOCHEnvoy MedicalN/A2.272.14PDEXPro-Dex0.323.672.14RXSTRxSightN/A10.208.93VANIVivani MedicalN/A3.183.18Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOCHEnvoy Medical8.59%PDEXPro-Dex15.28%RXSTRxSight78.78%VANIVivani Medical6.78%Insider OwnershipCompanyInsider OwnershipCOCHEnvoy Medical7.10%PDEXPro-Dex45.90%RXSTRxSight10.05%VANIVivani Medical53.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOCHEnvoy Medical3476.88 million71.42 millionNot OptionablePDEXPro-Dex1403.19 million1.73 millionNot OptionableRXSTRxSight22041.40 million37.24 millionOptionableVANIVivani Medical2086.24 million40.27 millionOptionableCOCH, VANI, RXST, and PDEX HeadlinesRecent News About These CompaniesVivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International ConventionJune 22 at 4:03 PM | globenewswire.comVivani Medical (NASDAQ:VANI) Director Gregg Williams Buys 1,587,301 SharesJune 17, 2026 | insidertrades.comVivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026May 28, 2026 | markets.businessinsider.comVivani Medical (NASDAQ:VANI) Director Buys $1,999,999.26 in StockMay 20, 2026 | insidertrades.comVivani Medical Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 13, 2026 | globenewswire.comVivani Medical (NASDAQ:VANI) Director Gregg Williams Purchases 1,587,301 SharesApril 17, 2026 | insidertrades.comWilliams Gregg buys Vivani medical (VANI) shares worth $1.99mApril 16, 2026 | investing.comVivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?April 3, 2026 | zacks.comVivani Medical price target lowered to $3.50 from $4 at H.C. WainwrightApril 2, 2026 | finance.yahoo.comVivani Medical (VANI) price target increased by 10.00% to 5.61March 28, 2026 | msn.comVivani completes first-in-human study of GLP-1 implantMarch 27, 2026 | drugdeliverybusiness.comDVivani Medical, Inc. Advances NPM-139 Semaglutide Implant toward Phase 1 Clinical Study Following Successful LIBERATE-1 Trial and Positive Preclinical DataMarch 26, 2026 | quiverquant.comQVivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateMarch 26, 2026 | globenewswire.comVivani Medical (NASDAQ:VANI) Director Buys $1,685,497.17 in StockMarch 17, 2026 | insidertrades.comVivani medical director Williams buys shares worth $1.68 millionMarch 16, 2026 | investing.comVivani Medical Introduces Long-Acting Implant for GLP-1 MedicationsMarch 3, 2026 | mddionline.comMWilliams Gregg buys Vivani medical (VANI) shares worth $1.98 millionFebruary 17, 2026 | investing.comCortigent reports positive 6-year findings for brain implant for providing artificial visionJanuary 29, 2026 | massdevice.comVivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026January 29, 2026 | globenewswire.comVivani Medical (NASDAQ:VANI) Director Gregg Williams Buys 1,351,351 SharesJanuary 29, 2026 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCOCH, VANI, RXST, and PDEX Company DescriptionsEnvoy Medical NASDAQ:COCH$0.64 -0.01 (-1.54%) As of 11:50 AM Eastern This is a fair market value price provided by Massive. Learn more.Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Pro-Dex NASDAQ:PDEX$64.79 +1.40 (+2.21%) As of 11:53 AM Eastern This is a fair market value price provided by Massive. Learn more.Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.RxSight NASDAQ:RXST$5.38 +0.17 (+3.16%) As of 11:54 AM Eastern This is a fair market value price provided by Massive. Learn more.RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.Vivani Medical NASDAQ:VANI$1.19 0.00 (0.00%) As of 11:50 AM Eastern This is a fair market value price provided by Massive. Learn more.Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas ASML’s Chip Dominance Runs Into New Silicon Boundaries Frozen Assets: How Super Micro Puts AI Heat on Ice The SpaceX Sell-Off May Be More Than a Market Overreaction Why These South Korea-Focused ETFs Have More Than Doubled in 2026 Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning Why nVent Could Be a Long-Term AI Infrastructure Winner These AI Stocks Have Insider Selling, But Buyers Still Have a Reason to Stay Chevron’s Microsoft Deal Turns Natural Gas Into an AI Trade Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
